12.31

7.10% 1.32

Envveno Medical Corp (NVNO)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Envveno Medical Corp stock is traded at $12.31, with a volume of 7,109. It is up +7.10% in the last 24 hours and up +9.03% over the past month. enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Previous Close:

$10.99

Open:

$11.09

24h Volume:

7,109

Relative Volume:

0.47

Market Cap:

$8.19M

Revenue:

Net Income/Loss:

$-18.82M

P/E Ratio:

-0.3947

EPS:

-31.1883

Net Cash Flow:

$-14.79M

1W Performance:

+15.96%

1M Performance:

+9.03%

6M Performance:

+35.76%

1Y Performance:

-93.15%

1-Day Range:

$10.15

$12.00

1-Week Range:

$10.15

$12.00

52-Week Range:

$8.67

$178.15

Envveno Medical Corp Stock (NVNO) Company Profile

Name

Envveno Medical Corp

Sector

Healthcare (1089)

Industry

Medical Devices (141)

Phone

949-261-2900

Address

70 DOPPLER, IRVINE

Employee

Twitter

Next Earnings Date

2026-07-30

Latest SEC Filings

NVNO's Discussions on Twitter

Compare NVNO vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NVNO Envveno Medical Corp	12.00	7.50M	0	-18.82M	-14.79M	-31.19
ABT Abbott Laboratories	109.67	192.51B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	331.73	130.11B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	90.54	116.83B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	51.48	75.11B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	90.67	52.80B	6.30B	1.07B	1.09B	1.8406

Envveno Medical Corp Stock (NVNO) Latest News

Aug 14, 2026

Perceptive Advisors (NVNO) reports 3.5% beneficial stake via 24,605 warrants - Stock Titan

Aug 14, 2026

Aug 04, 2026

enVVeno study shows $32,000 savings per patient for venous valve therapy - scanx.trade

Aug 04, 2026

enVVeno Medical (NVNO) Highlights Cost-Effectiveness of VenoValve Amid Challenging Valuation Metrics - GuruFocus

Aug 04, 2026

Independent Health Economic Study Recently Published in Journal of Vascular Surgery Reports Economic Dominance of enVVeno Medical's Replacement Venous Valve Therapy Compared to Standard of Care Treatments - ACCESS Newswire

Aug 04, 2026

enVVeno Study Projects About 2.2 Fewer Venous Ulcers Per Patient - Stock Titan

Aug 04, 2026

enVVeno cites Journal of Vascular Surgery study showing venous valve therapy saves more than $32,000 per patient over five years - Bitget

Aug 04, 2026

Jul 31, 2026

EnVVeno Moves Toward U.S. Pivotal Trial - Orange County Business Journal

Jul 31, 2026

enVVeno Medical receives FDA approval for pivotal trial By Investing.com - Investing.com Nigeria

Jul 31, 2026

enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical Replacement Venous Valve - Weatherford Democrat

Jul 31, 2026

enVVeno Medical gets FDA nod to start pivotal t... - Pluang

Jul 31, 2026

Jul 30, 2026

FDA IDE pivotal trial and 2027 cash runway for enVVeno Medical (NASDAQ: NVNO) - Stock Titan

Jul 30, 2026

Jul 29, 2026

NVNO Q2'26 Earnings: EPS estimate is (4.69) USD - TradingView

Jul 29, 2026

Jul 27, 2026